Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples